Frontlight ResearchEarly access
Lung cancer trials in Bosnia & Herzegovina
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
- Where
- Banja Luka, Mostar, Sarajevo, Zenica
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07130916